KR

Klaus Rose

klausrose Consulting, Granzer Regulatory Consultancy, Freie Universitat Berlin, Technische Universität Berlin, F Hoffman La Roche Ltd

ORCID iD 0000-0002-8304-1822

Employment

  • klausrose Consulting CEO
    2011 - 2014
  • Granzer Regulatory Consultancy Principal Consultant
    2010 - 2011
  • F Hoffman La Roche Ltd Global Head Pediatrics
    2005 - 2009
  • Novartis Pharma AG Global Head Pediatrics
    2001 - 2005
  • Novartis Pharma AG Senior International Medical Advisor
    1999 - 2000
  • Novartis Clinical Research Physician
    1997 - 1999
  • Byk Gulden Pharma Switzerland Medical Director
    1991 - 1996
  • Byk Gulden Pharma Clinical Research Physician
    1991 - 1996

Education

  • Freie Universitat Berlin M.D.
    1979 - 1986
  • Technische Universität Berlin M.S.
    1972 - 1978

Projects & Funding

Projects & funding information is unavailable.

Publications (3)

  • European UnionPediatric Legislation Jeopardizes Worldwide, Timely Future Advances in the Care of Children With Cancer
    Clinical Therapeutics 2014
    +Save
  • The Vision of Better Medicines for Children and the Role of Regulatory Authorities
    Pharmaceutical Regulatory Affairs: Open Access 2014
    +Save
  • Pediatric Epilepsy: Time For New Research Goals
    DOI: 10.20944/preprints202307.2136.v1
    +Save